Evidence map›Paper›PMID 23137415›Full record

ArticleInternational wound journal2014

Transplantation of BMSCs expressing hVEGF165 /hBD3 promotes wound healing in rats with combined radiation-wound injury.

Zhangquan Xia, Congji Zhang, Yi Zeng, Tao Wang, Guoping Ai

Abstract read
In one paragraph

Article in International wound journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. The effects of stem cells on burn wounds: a review.International journal of burns and trauma · 2019
    Review
  7. Article
  8. Article
  9. The Use of Stem Cells in Burn Wound Healing: A Review.BioMed research international · 2015
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhangquan XiaDepartment of Stomatology, Southwest Hospital, Third Military Medical University, Chongqing, ChinaDepartment of Stomatology, No 291 Hospital of the People's Liberation Army, Baotou, ChinaDepartment of Radiation Medicine, Institute of Combined Injury, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.
Congji Zhang
Yi Zeng
Tao Wang
Guoping Ai

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combined radiation-wound injury is a refractory wound with decreased number or dysfunction of repairing cells and growth factors. This remains a challenge in clinical practice. The object of this study is to evaluate the therapeutic efficacy of a combination of human vascular endothelial growth factor 165 (hVEGF(165)) and human beta-defensin 3 (hBD3) in the treatment of such wounds. A plasmid-carrying hVEGF(165) gene and hBD3 gene was used to transfect rat bone-marrow-derived mesenchymal stem cells (BMSCs). The supernatant from the modified BMSCs significantly promoted the proliferation and cell migration of human endothelial cells and it also inhibited the growth of bacteria and fungus, demonstrating the successful expression of the transfected genes. The hVEGF(165)/hBD3-modified BMSCs were then injected into the sites of combined radiation-wound injury on rats. It demonstrated that wound-healing time was shortened significantly in the treated rats. The granulation tissue formation/maturation, skin appendage regeneration and collagen deposition were also improved significantly. Strong expression of hVEGF(165) and hBD3 was detected in the wound surface at early stage of the healing. The results indicate that topical transplantation of hVEGF(165)/hBD3-modified BMSCs promoted wound healing, and this gene therapy strategy presents a promising approach in the treatment of refractory wounds such as the combined radiation-wound injury.

Indexed as

Animalsbeta-DefensinsCell ProliferationEndothelial CellsGenetic TherapyHumansMesenchymal Stem Cell TransplantationRadiation InjuriesRatsRats, Sprague-DawleyTransfectionVascular Endothelial Growth Factor AWound Healingbeta-DefensinsDEFB103A protein, humanVascular Endothelial Growth Factor AVEGFA protein, humanBone-marrow-derived mesenchymal stem cells; Human beta-defensin; Human vascular endothelial growth factor 165; Wound healing

Identifiers

PMID23137415
PMCPMC7950710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.